Patents Assigned to INNAVAC PTY LTD
  • Patent number: 9889195
    Abstract: The present invention provides an immunogenic composition comprising an antigen and a dendritic cell targeting component. A charged group is covalently attached to a dendritic cell ligand and is electrostatically associated with the dendritic cell targeting component.
    Type: Grant
    Filed: January 22, 2015
    Date of Patent: February 13, 2018
    Assignee: INNAVAC PTY LTD
    Inventors: David Charles Jackson, Weiguang Zeng, Brendon Yew Loong Chua
  • Patent number: 9676819
    Abstract: This invention relates to a method for treating or preventing a disease by raising an innate immune response in a subject, the method comprising administering to the subject an effective amount of a composition comprising a TLR2 moiety in solution, wherein the TLR2 moiety comprises a TLR2 agonist and wherein the disease is not treated or prevented by a humoral or cellular immune response directed against the TLR2 moiety.
    Type: Grant
    Filed: September 22, 2011
    Date of Patent: June 13, 2017
    Assignee: INNAVAC PTY LTD
    Inventors: David Charles Jackson, Amabel Tan, Weiguang Zeng